135 related articles for article (PubMed ID: 9020948)
21. [A phase II clinical study of cis-diammine glycolato platinum, 254-S, for advanced breast cancer].
Koyama H; Ogawa M; Kuraishi Y; Tominaga K; Yoshida M; Taguchi T
Gan To Kagaku Ryoho; 1992 Jul; 19(7):1049-53. PubMed ID: 1626940
[TBL] [Abstract][Full Text] [Related]
22. [Phase II study of YNK01 (1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate) on hematological malignancies].
Tatsumi N; Yamada K; Ohshima T; Nakamura T; Ohno R; Masaoka T; Kimura I; Kimura K
Gan To Kagaku Ryoho; 1990 Dec; 17(12):2387-95. PubMed ID: 2260876
[TBL] [Abstract][Full Text] [Related]
23. [Combination chemotherapy with nedaplatin, bleomycin and ifosfamide for advanced cervical cancer of the uterus--a preliminary study for phase III clinical study].
Noda K; Hirabayashi K; Terashima Y; Ozaki M; Yakushiji M; Hatae M; Kanazawa K
Gan To Kagaku Ryoho; 1997 Aug; 24(10):1285-93. PubMed ID: 9279348
[TBL] [Abstract][Full Text] [Related]
24. [Cooperative phase II study of epirubicin (EPI) in bladder cancer, renal pelvic and ureteral tumors--Urological Cooperative Study Group of EPI].
Niijima T; Koyanagi T; Maru A; Sakashita S; Koiso K; Ishikawa H; Uchida K; Shimazaki J; Isaka S; Akaza H
Hinyokika Kiyo; 1986 Sep; 32(9):1359-69. PubMed ID: 3468792
[TBL] [Abstract][Full Text] [Related]
25. Phase I and pharmacokinetic study of triapine, a potent ribonucleotide reductase inhibitor, administered daily for five days in patients with advanced solid tumors.
Murren J; Modiano M; Clairmont C; Lambert P; Savaraj N; Doyle T; Sznol M
Clin Cancer Res; 2003 Sep; 9(11):4092-100. PubMed ID: 14519631
[TBL] [Abstract][Full Text] [Related]
26. [A late phase II clinical study of S-1 in patients with progressed, refractory breast cancer].
Saeki T; Takashima S; Sano M; Horikoshi N; Miura S; Shimizu S; Morimoto K; Kimura M; Taguchi T
Gan To Kagaku Ryoho; 2004 Apr; 31(4):539-47. PubMed ID: 15114697
[TBL] [Abstract][Full Text] [Related]
27. [Early phase II study of amrubicin (SM-5887) for superficial bladder cancer: a dose-finding study for intravesical chemotherapy].
Tsushima T; Kobashi K; Akebi N; Yamato T; Asahi T; Maki Y; Ohmori H
Gan To Kagaku Ryoho; 2001 Apr; 28(4):483-91. PubMed ID: 11329782
[TBL] [Abstract][Full Text] [Related]
28. A phase I clinical trial of the histone deacetylase inhibitor belinostat in patients with advanced hematological neoplasia.
Gimsing P; Hansen M; Knudsen LM; Knoblauch P; Christensen IJ; Ooi CE; Buhl-Jensen P
Eur J Haematol; 2008 Sep; 81(3):170-6. PubMed ID: 18510700
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of the combination paclitaxel/carboplatin in patients with previously treated advanced ovarian carcinoma: a multicenter French Groupe des Investigateurs Nationaux pour l'Etude des Cancers Ovariens phase II study.
Pujade-Lauraine E; Guastalla JP; Weber B; Curé H; Orfeuvre H; Mousseau M; Vincent P; Diéras V; Tubiana-Mathieu N; Jacquin JP; Mignot L; Leduc B; Paraïso D; Viens P
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-30-S15-35. PubMed ID: 9346219
[TBL] [Abstract][Full Text] [Related]
30. [Phase II study of cis-diamminedichloroplatinum (II) in genitourinary cancer].
Gan To Kagaku Ryoho; 1982 Mar; 9(3):433-42. PubMed ID: 6764107
[TBL] [Abstract][Full Text] [Related]
31. [Early phase II study of TAT-59 in patients with advanced or recurrent breast cancer--a multicenter dose finding study].
Aoyama H; Tominaga T; Abe O
Gan To Kagaku Ryoho; 1998 May; 25(6):853-65. PubMed ID: 9617324
[TBL] [Abstract][Full Text] [Related]
32. A Phase 2 trial of the liposomal DACH platinum L-NDDP in patients with therapy-refractory advanced colorectal cancer.
Dragovich T; Mendelson D; Kurtin S; Richardson K; Von Hoff D; Hoos A
Cancer Chemother Pharmacol; 2006 Dec; 58(6):759-64. PubMed ID: 16847673
[TBL] [Abstract][Full Text] [Related]
33. Comparison of two-port and four-port irradiation in the bladder preservation therapy for locally invasive bladder cancer.
Sawada Y; Takeuchi Y; Iwasawa T; Kuroda K; Matsushima M; Nagamoto M; Wakayama M
Int J Urol; 2006 Dec; 13(12):1470-4. PubMed ID: 17118019
[TBL] [Abstract][Full Text] [Related]
34. [Results of clinical study with epirubicin hydrochloride injectable solution and cyclophosphamide in breast cancer].
Koyama H; Adachi I; Tajima T; Kanda K; Yoshida M; Miura S; Nakao K; Kikkawa N; Takai S; Toge T; Tamura K; Inaji H; Shiba E
Gan To Kagaku Ryoho; 1998 Sep; 25(11):1721-9. PubMed ID: 9757198
[TBL] [Abstract][Full Text] [Related]
35. Results of a European comparative randomized study comparing oral bropirimine versus intravesical BCG treatment in BCG-naive patients with carcinoma in situ of the urinary bladder. European Bropirimine Study Group.
Witjes WP; König M; Boeminghaus FP; Hall RR; Schulman CC; Zurlo M; Fittipaldo A; Riggi M; Debruyne FM
Eur Urol; 1999 Dec; 36(6):576-81. PubMed ID: 10559611
[TBL] [Abstract][Full Text] [Related]
36. [Concurrent chemoradiation therapy with nedaplatin for high-risk cervical cancer--clinical investigation of adverse events].
Kamiura S; Kobayashi K; Ohira H; Seino H; Hashimoto N; Sawai K; Samejima Y; Saji F
Gan To Kagaku Ryoho; 2001 Jul; 28(7):979-86. PubMed ID: 11478148
[TBL] [Abstract][Full Text] [Related]
37. [Late phase II study of MST-16 (sobuzoxane) efficacy for malignant lymphoma].
Masaoka T; Kageyama T; Tatsumi N; Akasaka K; Yonezawa T; Sugiyama H; Kitani T; Yasunaga K; Horiuchi A; Nakayama S
Gan To Kagaku Ryoho; 1992 Mar; 19(3):339-47. PubMed ID: 1543360
[TBL] [Abstract][Full Text] [Related]
38. FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma.
Mann BS; Johnson JR; Cohen MH; Justice R; Pazdur R
Oncologist; 2007 Oct; 12(10):1247-52. PubMed ID: 17962618
[TBL] [Abstract][Full Text] [Related]
39. [Early phase II study of KRN8602 (MX2), a novel anthracycline derivative for acute leukemia].
Takemoto Y; Sampi K; Kuraishi Y; Toki H; Tamura K; Ogawa M
Gan To Kagaku Ryoho; 1998 Dec; 25(14):2243-8. PubMed ID: 9881081
[TBL] [Abstract][Full Text] [Related]
40. [Phase II study on cis-diamminedichloroplatinum (II) by a collaborative study].
Gan To Kagaku Ryoho; 1982 Jan; 9(1):46-54. PubMed ID: 6892191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
